These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Dig Liver Dis; 2003 Sep; 35(9):619-27. PubMed ID: 14563183 [Abstract] [Full Text] [Related]
23. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. Kariyawasam VC, Selinger CP, Katelaris PH, Jones DB, McDonald C, Barr G, Chapman G, Colliwshaw J, Lunney PC, Middleton K, Wang RR, Huang T, Andrews J, Leong RW. Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785 [Abstract] [Full Text] [Related]
24. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature]. Klimczak K, Łykowska-Szuber L, Krela-Kaźmierczak I, Eder P, Szymczak A, Stawczyk-Eder K, Linke K. Wiad Lek; 2016 Aug; 69(2 Pt 2):262-6. PubMed ID: 27487545 [Abstract] [Full Text] [Related]
25. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice. Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA. J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899 [Abstract] [Full Text] [Related]
26. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease. Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV. World J Gastroenterol; 2014 Jul 21; 20(27):9185-90. PubMed ID: 25083093 [Abstract] [Full Text] [Related]
27. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C, Modigliani R, Rambaud JC. Lancet; 1996 Jan 27; 347(8996):215-9. PubMed ID: 8551879 [Abstract] [Full Text] [Related]
28. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease. Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S. Scand J Gastroenterol; 2015 Jan 27; 50(10):1208-13. PubMed ID: 25877164 [Abstract] [Full Text] [Related]
29. Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study. Park J, Chun J, Park SJ, Park JJ, Kim TI, Yoon H, Cheon JH. Dig Dis Sci; 2024 Mar 27; 69(3):901-910. PubMed ID: 38217678 [Abstract] [Full Text] [Related]
30. 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Maté-Jiménez J, Hermida C, Cantero-Perona J, Moreno-Otero R. Eur J Gastroenterol Hepatol; 2000 Nov 27; 12(11):1227-33. PubMed ID: 11111780 [Abstract] [Full Text] [Related]
31. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P. Inflamm Bowel Dis; 2009 Mar 27; 15(3):375-82. PubMed ID: 19009634 [Abstract] [Full Text] [Related]
32. Methotrexate in patients with Crohn's disease after 6-mercaptopurine. Mack DR, Young R, Kaufman SS, Ramey L, Vanderhoof JA. J Pediatr; 1998 May 27; 132(5):830-5. PubMed ID: 9602195 [Abstract] [Full Text] [Related]
33. Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease. Park JJ, Cheon JH, Hong SP, Kim TI, Kim WH. Dig Dis Sci; 2012 Jan 27; 57(1):133-41. PubMed ID: 22057283 [Abstract] [Full Text] [Related]
34. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Dassopoulos T, Sultan S, Falck-Ytter YT, Inadomi JM, Hanauer SB. Gastroenterology; 2013 Dec 27; 145(6):1464-78.e1-5. PubMed ID: 24267475 [No Abstract] [Full Text] [Related]
35. Use of methotrexate in patients with inflammatory bowel diseases. Preiss JC, Zeitz M. Clin Exp Rheumatol; 2010 Dec 27; 28(5 Suppl 61):S151-5. PubMed ID: 21044450 [Abstract] [Full Text] [Related]
37. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Nathan DM, Iser JH, Gibson PR. J Gastroenterol Hepatol; 2008 Jun 27; 23(6):954-8. PubMed ID: 17559377 [Abstract] [Full Text] [Related]
38. Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease. Gökbulut V, Özin Y, Kalkan İH, Arı D, Yüksel M, Kılıç ZMY, Kayaçetin E. Turk J Gastroenterol; 2022 Feb 27; 33(2):111-118. PubMed ID: 35115294 [Abstract] [Full Text] [Related]
39. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment? Sedano Muñoz R, Quera Pino R, Ibáñez Lazo P, Figueroa Corona C, Flores Pérez L. Gastroenterol Hepatol; 2019 May 27; 42(5):339-347. PubMed ID: 30954317 [Abstract] [Full Text] [Related]
40. A single-center experience with methotrexate in the treatment of Chinese Crohn's disease patients. Wang TR, Qiao YQ, Zou DW, Ran ZH. J Dig Dis; 2018 Dec 27; 19(12):753-758. PubMed ID: 30516330 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]